Figure 7.
Selective incorporation of the fluorescent analogue PTE-ET-18-OCH3 in human leukemic cells. Human leukemic Jurkat cells were incubated with the indicated concentrations of ET-18-OCH3 or PTE-ET-18-OCH3 for 24 h and apoptosis was measured by flow cytometry (A). Normal PBLs and leukemic HL-60 and Jurkat cells (JK) were treated with 20 μM PTE-ET-18-OCH3 for 7 h, washed with 1% BSA-PBS, and fluorescent drug uptake was analyzed by fluorescence microscopy (blue fluorescence) (B) or by fluorescence quantitation (C). Data shown are means ± SD of three independent determinations.